Amikacin sulfate injection is an aminoglycoside antibiotic used to treat serious bacterial infections. It is typically administered by healthcare professionals via intramuscular injection or intravenous infusion [1].
When does amikacin sulfate injection's patent exclusivity expire?
Patent exclusivity for amikacin sulfate injection has largely expired, as it is an older antibiotic. The original patents for amikacin date back to the 1970s. However, there may be newer patents related to specific formulations, delivery methods, or combination therapies that could still be in effect [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals and can provide details on specific patents related to amikacin [3].
How does amikacin sulfate injection work?
Amikacin sulfate injection works by binding to the bacterial 30S ribosomal subunit. This binding interferes with protein synthesis, leading to the production of faulty proteins and ultimately bacterial cell death. It is effective against a range of Gram-negative bacteria, including Escherichia coli, Proteus species, Pseudomonas aeruginosa, and Klebsiella species, as well as some Gram-positive bacteria like Staphylococcus aureus [1].
What are the risks and side effects of amikacin sulfate injection?
Like other aminoglycosides, amikacin sulfate injection carries risks of nephrotoxicity (kidney damage) and ototoxicity (hearing or balance impairment). These risks can be dose-dependent and may be exacerbated by prolonged use or pre-existing kidney or hearing conditions. Other potential side effects include nausea, vomiting, rash, and headache [1]. Regular monitoring of kidney function and hearing is often recommended during treatment [4].
Are there alternatives to amikacin sulfate injection for bacterial infections?
Yes, several alternative antibiotics are available for treating bacterial infections, depending on the specific pathogen and its susceptibility. These may include other aminoglycosides (though many have similar toxicity profiles), cephalosporins, penicillins, macrolides, fluoroquinolones, and carbapenems [4]. The choice of antibiotic is guided by culture and sensitivity testing.
Can amikacin sulfate injection be used in specific patient populations?
Amikacin sulfate injection requires careful consideration in patients with renal impairment, as its elimination is primarily through the kidneys. Dosing adjustments are often necessary to prevent accumulation and reduce the risk of toxicity. Its use in pregnant or breastfeeding women is generally avoided unless the potential benefits outweigh the risks, due to potential fetal harm [4].
What is the typical cost of amikacin sulfate injection?
The cost of amikacin sulfate injection can vary depending on the manufacturer, dosage, and the healthcare setting where it is administered. As an older, generic medication, it is generally considered more affordable than newer, branded antibiotics.
Sources:
1. https://www.ncbi.nlm.nih.gov/books/NBK557894/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/drug/amikacin-sulfate
4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878749/